Vitekta

Land: New Zealand

Språk: engelsk

Kilde: Medsafe (Medicines Safety Authority)

Aktiv ingrediens:

Elvitegravir 150mg;  ;  ;  ;  

Tilgjengelig fra:

Gilead Sciences (NZ)

INN (International Name):

Elvitegravir 150 mg

Dosering :

150 mg

Legemiddelform:

Film coated tablet

Sammensetning:

Active: Elvitegravir 150mg         Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry green 85F91203 Sodium laurilsulfate

Resept typen:

Prescription

Produsert av:

Catalent Micron Technologies Inc

Indikasjoner:

Indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.

Produkt oppsummering:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with child resistant PE cap - 30 tablets - 24 months from date of manufacture stored at or below 25°C

Autorisasjon dato:

2013-11-04